相关实验视频

Updated: Sep 14, 2025

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

PPM1M是一种LRRK2抑制的,Rab12偏好的酸酶,与帕金森病有潜在的联系

Claire Y Chiang¹, Neringa Pratuseviciute², Yu-En Lin¹

¹Department of Biochemistry, Stanford University School of Medicine, Stanford, CA, USA; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA.

|July 21, 2025

概括

蛋白质酸酶依赖的1M (PPM1M) 解化关键Rab GTPases参与帕金森病的发病. PPM1M 缺乏导致神经元缺陷,其突变与帕金森病有关,这表明它是一个治疗点.

科学领域:

分子生物学分子生物学
神经科学是一个神经科学.
生物化学生物化学

背景情况:

氨酸丰富的重复激酶2 (LRRK2) 激活突变与帕金森病 (PD) 有关.
LRRK2酸化Rab GTPases,这种过程可以通过像PPM1H这样的酸酶逆转.
酸化拉布GTPases在受体贩运和神经元功能中发挥作用.

研究的目的:

为了识别参与LRRK2信号通路的酸酶.
调查PPM1M在Rab GTPase脱化中的作用及其与PD的相关性.

主要方法:

进行了全酸小干扰RNA (siRNA) 选.
利用淘汰细胞和小鼠模型来研究PPM1M的功能.
分析了PPM1M在体外和细胞中的活性,包括患者衍生的突变.

主要成果:

确定PPM1M是一种酶,偏好Rab12,也对Rab8A和Rab10起作用.
细胞和小鼠中的PPM1M淘汰导致特定神经元群体的初级乳毛损失.
在帕金森病患者中发现了一种罕见的,催化不活的PPM1M突变.

结论:

PPM1M是LRRK2信号通路中的关键酸酶.
PPM1M功能障碍与帕金森病的发病有关.
PPM1M代表了帕金森病的潜在治疗点.

关键词:

CP: 细胞生物学细胞生物学科普:神经科学是什么意思在LRRK2激酶中,帕金森病是帕金森氏症的一种疾病.拉布拉布GTPase可以使用.酸酶是一种酸酶.主要的乳毛是主要的乳毛.

更多相关视频

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Published on: March 21, 2020

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...